Successful use of Rectal Pregabalin for the Treatment of Chemotherapy-Induced Neuropathic Pain—a Case Report

Author:

Roch Carmen1ORCID,Para Servet1,Brandhofer Christine2,Seitz Anna K.3,Rémi Constanze45ORCID,Berner Jennifer45,van Oorschot Birgitt1

Affiliation:

1. Interdisciplinary Center for Palliative Medicine, University Hospital Wuerzburg, Wuerzburg, Germany

2. Pharmacy of the University Hospital Wuerzburg, Wuerzburg, Germany

3. Department of Urology and Pediatric Urology, University Hospital Wuerzburg, Wuerzburg, Germany

4. Pharmacy University Hospital of Munich, Munich, Germany

5. Department for Palliative Medicine, University Hospital of Munich, Munich, Germany

Abstract

Introduction A 65-year-old female patient could no longer take oral food or medications due to a duodenal occlusion associated with metastatic urothelial carcinoma. Her pre-existing chemotherapy-induced polyneuropathy had been well treated with pregabalin orally. Methods Since only preparations for oral use of pregabalin are available, pregabalin suppositories were compounded by the hospital pharmacy for rectal use in this patient. Results With the rectal administration, the treatment was successfully continued; we measured a good increase in serum levels and the symptoms improved significantly. Discussion Cancer patients often need to be treated with co-analgesics. At the end of life, treatment often cannot be continued due to lack of other than oral administration. Our case adds to the low evidence of pregabalin administered rectally.

Publisher

SAGE Publications

Subject

General Medicine

Reference13 articles.

1. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain

2. Pharmacokinetic and pharmacodynamic studies of pregabalin suppositories based on pharmacological research

3. Successful use of pregabalin by the rectal route to treat chronic neuropathic pain in a patient with complete intestinal failure: Table 1

4. DAC-Anlage F Verdrängungsfaktoren für Zäpfchen und Vaginalzäpfchen Stand DAC 2019-2 [Internet]. Avoxa: Mediengruppe Deutscher Apotheker GmbH. 2018. http:// dacnrf. pharmazeutische- zeitung.de Accessed 06 April 2023. https://dacnrf.pharmazeutische-zeitung.de

5. German Guideline Programme in Oncology (German Cancer Society, German Cancer Aid, AWMF): Supportive Therapie for oncologic patients - long version 1.3, 2020, AWMF registration number: 032/054OL, https://www.leitlinienprogramm- onkologie.de/leitlinien/supportive-therapie/ (Accessed 06 April 2023). 2020.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3